| Year |
Citation |
Score |
| 2023 |
Dailey KM, Small JM, Pullan JE, Winfree S, Vance KE, Orr M, Mallik S, Bayles KW, Hollingsworth MA, Brooks AE. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183. PMID 37963142 DOI: 10.1371/journal.pone.0289183 |
0.761 |
|
| 2023 |
Roe JM, Seely K, Bussard CJ, Eischen Martin E, Mouw EG, Bayles KW, Hollingsworth MA, Brooks AE, Dailey KM. Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria. Pharmaceutics. 15. PMID 37514190 DOI: 10.3390/pharmaceutics15072004 |
0.771 |
|
| 2022 |
Pullan J, Dailey K, Bhallamudi S, Feng L, Alhalhooly L, Froberg J, Osborn J, Sarkar K, Molden T, Sathish V, Choi Y, Brooks A, Mallik S. Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells. Acs Applied Bio Materials. PMID 35417133 DOI: 10.1021/acsabm.2c00015 |
0.745 |
|
| 2022 |
Mulinti P, Diekjürgen D, Kurtzeborn K, Balasubramanian N, Stafslien SJ, Grainger DW, Brooks AE. Anti-Coagulant and Antimicrobial Recombinant Heparin-Binding Major Ampullate Spidroin 2 (MaSp2) Silk Protein. Bioengineering (Basel, Switzerland). 9. PMID 35200400 DOI: 10.3390/bioengineering9020046 |
0.457 |
|
| 2021 |
Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel, Switzerland). 11. PMID 34835785 DOI: 10.3390/nano11113018 |
0.761 |
|
| 2021 |
Dailey KM, Jacobson RI, Johnson PR, Woolery TJ, Kim J, Jansen RJ, Mallik S, Brooks AE. Methods and Techniques to Facilitate the Development of NT as an Effective, Therapeutic Oncolytic Bacteria. Frontiers in Microbiology. 12: 624618. PMID 33854487 DOI: 10.3389/fmicb.2021.624618 |
0.769 |
|
| 2021 |
Dailey KM, Allgood JE, Johnson PR, Ostlie MA, Brooks BD, Brooks AE, Schaner KC. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering. Future Microbiology. PMID 33754804 DOI: 10.2217/fmb-2020-0245 |
0.768 |
|
| 2019 |
Shreffler JW, Pullan JE, Dailey KM, Mallik S, Brooks AE. Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification. International Journal of Molecular Sciences. 20. PMID 31801303 DOI: 10.3390/Ijms20236056 |
0.751 |
|
| 2018 |
Hoffmann B, Gruat-Henry C, Mulinti P, Jiang L, Brooks BD, Brooks AE. Using hydrodynamic focusing to predictably alter the diameter of synthetic silk fibers. Plos One. 13: e0195522. PMID 29649239 DOI: 10.1371/Journal.Pone.0195522 |
0.336 |
|
| 2016 |
Pullan JE, Pullan AT, Taylor VB, Brooks BD, Ewert D, Brooks AE. Energy-triggered drug release from polymer nanoparticles for orthopedic applications. Therapeutic Delivery. PMID 27982749 DOI: 10.4155/Tde-2016-0066 |
0.308 |
|
| 2016 |
Yang X, Xu Y, Brooks A, Guo B, Miskimins KW, Qian SY. Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs. Free Radical Biology & Medicine. PMID 27368132 DOI: 10.1016/J.Freeradbiomed.2016.06.028 |
0.301 |
|
| 2015 |
Davidoff SN, Au D, Gale BK, Brooks BD, Brooks AE. Maximizing Fibroblast Adhesion on Protein-Coated Surfaces Using Microfluidic Cell Printing. Rsc Advances. 5: 104101-104109. PMID 26989480 DOI: 10.1039/C5Ra18673K |
0.311 |
|
| 2015 |
Brooks AE. The Potential of Silk and Silk-Like Proteins as Natural Mucoadhesive Biopolymers for Controlled Drug Delivery. Frontiers in Chemistry. 3: 65. PMID 26636069 DOI: 10.3389/Fchem.2015.00065 |
0.303 |
|
| 2015 |
Jones Z, Brooks AE, Ferrell Z, Grainger DW, Sinclair KD. A resorbable antibiotic eluting bone void filler for periprosthetic joint infection prevention. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. PMID 26332762 DOI: 10.1002/Jbm.B.33513 |
0.504 |
|
| 2015 |
Brooks BD, Sinclair KD, Grainger DW, Brooks AE. A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model. Plos One. 10: e0118696. PMID 25815727 DOI: 10.1371/Journal.Pone.0118696 |
0.516 |
|
| 2014 |
Degooyer J, Davidoff SN, Brooks BD, Grainger DW, Brooks AE. Polymer-controlled extended combination release of silver and chlorhexidine from a bone void filler. Biomedical Sciences Instrumentation. 50: 47-53. PMID 25405403 |
0.465 |
|
| 2014 |
Brooks BD, Sinclair KD, Davidoff SN, Lawson S, Williams AG, Coats B, Grainger DW, Brooks AE. Molded polymer-coated composite bone void filler improves tobramycin controlled release kinetics. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 102: 1074-83. PMID 24376164 DOI: 10.1002/Jbm.B.33089 |
0.527 |
|
| 2013 |
Brooks AE, Brooks BD, Davidoff SN, Hogrebe PC, Fisher MA, Grainger DW. Polymer-controlled release of tobramycin from bone graft void filler. Drug Delivery and Translational Research. 3: 518-30. PMID 25786372 DOI: 10.1007/S13346-013-0155-X |
0.511 |
|
| 2013 |
Davidoff SN, Lawson ST, Grainger DW, Brooks AE. Scanning electron image analysis to monitor of implant degradation and host healing following implantation of a drug-eluting bone graft void filler - biomed 2013. Biomedical Sciences Instrumentation. 49: 165-71. PMID 23686196 |
0.443 |
|
| 2013 |
Brooks BD, Brooks AE, Grainger DW. Antimicrobial medical devices in preclinical development and clinical use Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies. 307-354. DOI: 10.1007/978-1-4614-1031-7_13 |
0.447 |
|
| 2012 |
Jones CF, Campbell RA, Brooks AE, Assemi S, Tadjiki S, Thiagarajan G, Mulcock C, Weyrich AS, Brooks BD, Ghandehari H, Grainger DW. Cationic PAMAM dendrimers aggressively initiate blood clot formation. Acs Nano. 6: 9900-10. PMID 23062017 DOI: 10.1021/Nn303472R |
0.632 |
|
| 2011 |
Diekjürgen D, Astashkina A, Grainger DW, Holt D, Brooks AE. Cultured Primary Macrophage Activation by Lipopolysaccharide Depends on Adsorbed Protein Composition and Substrate Surface Chemistry. Journal of Biomaterials Science. Polymer Edition. PMID 21722418 DOI: 10.1163/092050611X580382 |
0.726 |
|
| 2011 |
Davidoff SN, Sevy JO, Brooks BD, Grainger DW, Brooks AE. Evaluating antibiotic release profiles as a function of polymer coating formulation - biomed 2011. Biomedical Sciences Instrumentation. 47: 46-51. PMID 21525595 |
0.467 |
|
| 2011 |
Creager MS, Izdebski T, Brooks AE, Lewis RV. Elucidating metabolic pathways for amino acid incorporation into dragline spider silk using 13C enrichment and solid state NMR. Comparative Biochemistry and Physiology. Part a, Molecular & Integrative Physiology. 159: 219-24. PMID 21334448 DOI: 10.1016/J.Cbpa.2011.02.010 |
0.741 |
|
| 2010 |
Creager MS, Jenkins JE, Thagard-Yeaman LA, Brooks AE, Jones JA, Lewis RV, Holland GP, Yarger JL. Solid-state NMR comparison of various spiders' dragline silk fiber. Biomacromolecules. 11: 2039-43. PMID 20593757 DOI: 10.1021/Bm100399X |
0.76 |
|
| 2010 |
Davidoff SN, Call BP, Hogrebe PC, Grainger DW, Brooks AE. A robust method to coat allograft bone with a drug-releasing polymer shell - biomed 2010. Biomedical Sciences Instrumentation. 46: 184-9. PMID 20467092 |
0.461 |
|
| 2010 |
Sevy JO, Slawson MH, Grainger DW, Brooks AE. Assay method for polymer-controlled antibiotic release from allograft bone to target orthopaedic infections - biomed 2010. Biomedical Sciences Instrumentation. 46: 136-41. PMID 20467084 |
0.468 |
|
| 2009 |
Brooks AE, Brooks BD, Creager MS, Lewis RV. Analyzing the clustering effects of major ampullate silk mechanical properties - biomed 2009. Biomedical Sciences Instrumentation. 45: 232-7. PMID 19369768 |
0.762 |
|
| 2009 |
Brooks B, Brooks A, Wulff SS, Lewis RV. Identification of problems developing an ultrasensitive immunoassay for the ante mortem detection of the infectious isoform of the CWD-associated prion protein. Journal of Immunoassay & Immunochemistry. 30: 135-49. PMID 19330640 DOI: 10.1080/15321810902782848 |
0.509 |
|
| 2009 |
Teulé F, Cooper AR, Furin WA, Bittencourt D, Rech EL, Brooks A, Lewis RV. A protocol for the production of recombinant spider silk-like proteins for artificial fiber spinning. Nature Protocols. 4: 341-55. PMID 19229199 DOI: 10.1038/Nprot.2008.250 |
0.583 |
|
| 2008 |
Brooks AE, Nelson SR, Jones JA, Koenig C, Hinman M, Stricker S, Lewis RV. Distinct contributions of model MaSp1 and MaSp2 like peptides to the mechanical properties of synthetic major ampullate silk fibers as revealed in silico. Nanotechnology, Science and Applications. 1: 9-16. PMID 20657704 DOI: 10.2147/Nsa.S3961 |
0.591 |
|
| 2008 |
Brooks AE, Stricker SM, Joshi SB, Kamerzell TJ, Middaugh CR, Lewis RV. Properties of synthetic spider silk fibers based on Argiope aurantia MaSp2. Biomacromolecules. 9: 1506-10. PMID 18457450 DOI: 10.1021/Bm701124P |
0.581 |
|
| 2007 |
Brooks AE, Brothers TJ, Creager MS, Lewis RV. A novel methodology to explore the viscoelasticity of spider major ampullate silk. Journal of Applied Biomaterials & Biomechanics : Jabb. 5: 158-65. PMID 20799185 DOI: 10.5301/Jabb.2008.1423 |
0.759 |
|
| 2005 |
Brooks AE, Steinkraus HB, Nelson SR, Lewis RV. An investigation of the divergence of major ampullate silk fibers from Nephila clavipes and Argiope aurantia. Biomacromolecules. 6: 3095-9. PMID 16283732 DOI: 10.1021/Bm050421E |
0.579 |
|
| 2005 |
Brooks AE, Creager MS, Lewis RV. Altering the mechanics of spider silk through methanol post-spin drawing. Biomedical Sciences Instrumentation. 41: 1-6. PMID 15850073 |
0.754 |
|
| 2004 |
Brooks AE, Lewis RV. Probing the elastic nature of spider silk in pursuit of the next designer fiber. Biomedical Sciences Instrumentation. 40: 232-7. PMID 15133963 |
0.535 |
|
| Show low-probability matches. |